S&P 500   3,798.91
DOW   30,930.52
QQQ   316.71
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.71
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.71
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.71
pixel
Log in
NASDAQ:OPRX

OptimizeRx Stock Forecast, Price & News

$41.83
+2.29 (+5.79 %)
(As of 01/19/2021 03:59 PM ET)
Add
Compare
Today's Range
$40.51
Now: $41.83
$45.37
50-Day Range
$25.15
MA: $31.27
$39.99
52-Week Range
$6.50
Now: $41.83
$40.51
Volume11,974 shs
Average Volume144,900 shs
Market Capitalization$632.05 million
P/E RatioN/A
Dividend YieldN/A
Beta0.82
OptimizeRx Corporation operates as a digital health company that facilitates communication at point-of-care among various stakeholders in healthcare. Its cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, and critical clinical information; and network consists of electronic health record company platforms, which provide the ambulatory patient market with access to their workflow at the point-of-care. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and clinical messaging services. The company's products and applications also comprise brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.

MarketRank

Overall MarketRank

1.49 out of 5 stars

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
Current SymbolNASDAQ:OPRX
CUSIPN/A
CIKN/A
Phone248-651-6568
Employees70

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$24.60 million
Book Value$3.17 per share

Profitability

Net Income$-3,140,000.00

Miscellaneous

Market Cap$632.05 million
Next Earnings Date2/25/2021 (Estimated)
OptionableNot Optionable
$41.83
+2.29 (+5.79 %)
(As of 01/19/2021 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OPRX News and Ratings via Email

Sign-up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











OptimizeRx (NASDAQ:OPRX) Frequently Asked Questions

How has OptimizeRx's stock price been impacted by Coronavirus (COVID-19)?

OptimizeRx's stock was trading at $7.51 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, OPRX shares have increased by 455.0% and is now trading at $41.68.
View which stocks have been most impacted by COVID-19
.

Is OptimizeRx a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OptimizeRx in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" OptimizeRx stock.
View analyst ratings for OptimizeRx
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than OptimizeRx?

Wall Street analysts have given OptimizeRx a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but OptimizeRx wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is OptimizeRx's next earnings date?

OptimizeRx is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for OptimizeRx
.

How were OptimizeRx's earnings last quarter?

OptimizeRx Co. (NASDAQ:OPRX) posted its quarterly earnings results on Monday, November, 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.02) by $0.01. The firm had revenue of $10.52 million for the quarter, compared to analyst estimates of $10.04 million. OptimizeRx had a negative return on equity of 10.86% and a negative net margin of 16.20%.
View OptimizeRx's earnings history
.

What price target have analysts set for OPRX?

3 equities research analysts have issued 1-year price targets for OptimizeRx's shares. Their forecasts range from $40.00 to $70.00. On average, they expect OptimizeRx's share price to reach $53.33 in the next year. This suggests a possible upside of 28.0% from the stock's current price.
View analysts' price targets for OptimizeRx
or view Wall Street analyst' top-rated stocks.

Who are some of OptimizeRx's key competitors?

What other stocks do shareholders of OptimizeRx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OptimizeRx investors own include InterDigital (IDCC), Bank of Hawaii (BOH), NVIDIA (NVDA), STAG Industrial (STAG), Etsy (ETSY), Marvell Technology Group (MRVL), The Trade Desk (TTD), Verizon Communications (VZ), Advanced Micro Devices (AMD) and Amgen (AMGN).

Who are OptimizeRx's key executives?

OptimizeRx's management team includes the following people:
  • Mr. William J. Febbo, CEO & Director (Age 51, Pay $442.19k)
  • Ms. Miriam J. Paramore, Pres (Age 57, Pay $331.75k)
  • Mr. Douglas P. Baker, Chief Financial Officer (Age 63, Pay $318.93k)
  • Mr. Stephen L. Silvestro, Chief Commercial Officer (Age 42, Pay $271.5k)
  • Mr. Todd Inman, Chief Technology Officer
  • Mr. Terence J. Hamilton, Sr. VP of Pharma (Age 55)
  • Mr. Srdjan Loncar, Head of Patient Engagement Solutions
  • Ms. Rebecca Whitney, Sr. VP of Commercial Operations
  • Mr. Angelo Campano, Sr. VP & Principal of Agency Channels
  • Ms. Heather Favazza, Controller

What is OptimizeRx's stock symbol?

OptimizeRx trades on the NASDAQ under the ticker symbol "OPRX."

How do I buy shares of OptimizeRx?

Shares of OPRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is OptimizeRx's stock price today?

One share of OPRX stock can currently be purchased for approximately $41.68.

How big of a company is OptimizeRx?

OptimizeRx has a market capitalization of $629.78 million and generates $24.60 million in revenue each year. The company earns $-3,140,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis. OptimizeRx employs 70 workers across the globe.

What is OptimizeRx's official website?

The official website for OptimizeRx is www.optimizerx.com.

How can I contact OptimizeRx?

OptimizeRx's mailing address is 400 WATER STREET SUITE 200, ROCHESTER MI, 48307. The company can be reached via phone at 248-651-6568 or via email at op[email protected]

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.